Comments
Loading...
AbCellera Biologics Earnings Estimates, EPS & Revenue | NASDAQ:ABCL | Benzinga
AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.170
Quarterly Revenue Estimate
$11.81M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$28.83M
Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCL | AbCellera Biologics | -$0.14 | -$0.17 | — | — | $9.95M | $11.81M | — | — | 05/06/2025 | Get Alert |
| ABCL | AbCellera Biologics | -$0.16 | -$0.15 | -$0.12 | 20.00% | $9.18M | $7.58M | $5.10M | -32.72% | 02/27/2025 | Get Alert |
| ABCL | AbCellera Biologics | -$0.10 | -$0.15 | -$0.17 | -13.33% | $6.60M | $7.95M | $6.51M | -18.15% | 11/04/2024 | Get Alert |
| ABCL | AbCellera Biologics | -$0.11 | -$0.14 | -$0.13 | 7.14% | $10.06M | $10.15M | $7.32M | -27.85% | 08/06/2024 | Get Alert |
| ABCL | AbCellera Biologics | -$0.14 | -$0.17 | -$0.14 | 17.65% | $12.19M | $10.84M | $9.95M | -8.17% | 05/07/2024 | Get Alert |
| ABCL | AbCellera Biologics | -$0.10 | -$0.13 | -$0.16 | -23.08% | $21.55M | $8.88M | $9.18M | 3.37% | 02/20/2024 | Get Alert |
| ABCL | AbCellera Biologics | $0.08 | -$0.13 | -$0.10 | 23.08% | $101.38M | $11.90M | $6.60M | -44.55% | 11/02/2023 | Get Alert |
| ABCL | AbCellera Biologics | -$0.02 | -$0.13 | -$0.11 | 15.38% | $45.92M | $12.37M | $10.06M | -18.71% | 08/03/2023 | Get Alert |
| ABCL | AbCellera Biologics | $0.54 | -$0.14 | -$0.14 | 0.00% | $316.58M | $12.11M | $12.19M | 0.68% | 05/04/2023 | Get Alert |
| ABCL | AbCellera Biologics | $0.19 | $0.00 | -$0.10 | -100.00% | $139.33M | $50.80M | $21.55M | -57.59% | 02/21/2023 | Get Alert |
| ABCL | AbCellera Biologics | -$0.08 | $0.04 | $0.08 | 100.00% | $5.51M | $74.95M | $101.38M | 35.27% | 11/08/2022 | Get Alert |
| ABCL | AbCellera Biologics | -$0.01 | -$0.02 | -$0.02 | 0.00% | $27.64M | $53.59M | $45.92M | -14.32% | 08/09/2022 | Get Alert |
| ABCL | AbCellera Biologics | $0.37 | $0.33 | $0.54 | 63.64% | $202.74M | $194.67M | $316.58M | 62.62% | 05/10/2022 | Get Alert |
| ABCL | AbCellera Biologics | $0.44 | $0.19 | $0.19 | 0.00% | $207.91M | $122.05M | $139.33M | 14.16% | 02/24/2022 | Get Alert |
| ABCL | AbCellera Biologics | -$0.02 | — | -$0.08 | — | $9.36M | — | $5.51M | — | 11/09/2021 | Get Alert |
| ABCL | AbCellera Biologics | — | $0.11 | -$0.01 | -109.09% | — | $87.32M | $27.64M | -68.34% | 08/12/2021 | Get Alert |
| ABCL | AbCellera Biologics | — | $0.38 | $0.37 | -2.63% | — | $196.48M | $202.74M | 3.19% | 05/13/2021 | Get Alert |
AbCellera Biologics (ABCL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.12 | $-0.15 | 20.0 % |
| Q3 | 2024-11-04 | $-0.17 | $-0.15 | -13.3 % |
| Q2 | 2024-08-06 | $-0.13 | $-0.14 | 7.14 % |
| Q1 | 2024-05-07 | $-0.14 | $-0.17 | 17.6 % |
AbCellera Biologics (ABCL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $5.10M | $7.58M | -32.7 % |
| Q3 | 2024-11-04 | $6.51M | $7.95M | -18.1 % |
| Q2 | 2024-08-06 | $7.32M | $10.15M | -27.9 % |
| Q1 | 2024-05-07 | $9.95M | $10.84M | -8.17 % |
FAQ
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
AbCellera Biologics (ABCL) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?
The Actual EPS was $-0.12, which beat the estimate of $-0.15.
What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?
The Actual Revenue was $5.1M, which missed the estimate of $7.6M.
Browse earnings estimates, EPS, and revenue on all stocks.